Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMCR Immunocore Holdings plc

盘后交易 05-02 17:51:15 EDT

59.46

+0.41

+0.69%

盘后59.45

-0.01-0.02%

17:51 EDT

最高60.90	最低58.76	成交量39.68万
今开59.66	昨收59.05	日振幅3.62%
总市值30.01亿	流通市值19.54亿	总股本5,047万
成交额2,354万	换手率1.21%	流通股本3,287万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMCR","market":"US","secType":"STK","nameCN":"Immunocore Holdings plc","latestPrice":59.46,"timestamp":1714680000000,"preClose":59.05,"halted":0,"volume":396830,"hourTrading":{"tag":"盘后","latestPrice":59.45,"preClose":59.46,"latestTime":"17:51 EDT","volume":2854,"amount":169698.81146,"timestamp":1714686670712},"delay":0,"floatShares":32867904,"shares":50470672,"eps":-1.130868,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.41,"latestTime":"05-02 17:51:15 EDT","open":59.66,"high":60.9,"low":58.76,"amount":23535459.5161,"amplitude":0.03624,"askPrice":64.97,"askSize":100,"bidPrice":53.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.130868,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714694400000},"adr":0,"listingDate":1612501200000,"adjPreClose":59.05,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":59.45,"preClose":59.46,"latestTime":"17:51 EDT","volume":2854,"amount":169698.81146,"timestamp":1714686670712},"volumeRatio":0.868516},"requestUrl":"/m/hq/s/IMCR/","defaultTab":"news","newsList":[{"id":"2426387237","title":"Needham：重申Immunocore Hldgs(IMCR.US)评级，由买入调整至买入评级, 目标价81.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426387237","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426387237?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:45","pubTimestamp":1712832332,"startTime":"0","endTime":"0","summary":"Needham：重申Immunocore Hldgs(IMCR.US)评级，由买入调整至买入评级, 目标价81.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411184535876734da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411184535876734da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426923105","title":"Immunocore Hldgs Plc盘中异动 急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426923105","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426923105?lang=zh_cn&edition=full","pubTime":"2024-04-09 03:49","pubTimestamp":1712605779,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日03时49分，Immunocore Hldgs Plc股票出现异动，股价大幅下挫5.13%。截至发稿，该股报60.24美元/股，成交量16.0774万股，换手率0.32%，振幅5.61%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.18%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409034939861e3fbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409034939861e3fbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416906719","title":"Immunocore Hldgs Plc2023财年实现净利润-55.50百万美元，同比减少9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416906719","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416906719?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:19","pubTimestamp":1709482744,"startTime":"0","endTime":"0","summary":"12月31日，Immunocore Hldgs Plc公布财报，公告显示公司2023财年净利润为-55.50百万美元，同比减少9.29%；其中营业收入为2.50亿美元，同比增加41.24%，每股基本收益为-1.14美元。从资产负债表来看，Immunocore Hldgs Plc总负债2.28亿美元，其中短期债务1.39百万美元，资产负债比为2.62，流动比率为3.81。机构评级：截至2023年12月31日，当前有15家机构对Immunocore Hldgs Plc目标价做出预测，其中目标均价为85.13美元，其中最低目标价为63.00美元，最高目标价为92.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400191387e0de6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400191387e0de6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407559518","title":"Immunocore Hldgs Plc盘中异动 早盘急速拉升5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407559518","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407559518?lang=zh_cn&edition=full","pubTime":"2024-01-31 22:30","pubTimestamp":1706711447,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日22时30分，Immunocore Hldgs Plc股票出现波动，股价大幅上涨5.85%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Neximmune Inc、Ensysce Biosciences Inc、Revelation Biosciences Inc涨幅较大，Revelation Biosciences Inc、Ensysce Biosciences Inc、Neximmune Inc较为活跃，换手率分别为288.89%、275.43%、107.42%，振幅较大的相关个股有Onconetix Inc、珐博进、Virax Biolabs Group Limited，振幅分别为7.77%、7.27%、6.99%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131223048790de10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131223048790de10c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407984361","title":"BUZZ--美国股票走势-SLB、康宁、2seventy 生物公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2407984361","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407984361?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:02","pubTimestamp":1706630549,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月30日 -    华尔街周二下滑，此前联合包裹服务公司和通用汽车公司的盈利喜忧参半，劳动力市场数据也有弹性，抑制了提前开始降息的预期。美东时间10:36，道琼斯工业平均指数  下跌0.15%，报38,274.27点。标普500指数  下跌0.10%，报4922.85点；纳斯达克综合指数  下跌0.27%，报15585.688点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407683973","title":"Immunocore Hldgs Plc盘中异动 股价大跌8.32%报66.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407683973","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407683973?lang=zh_cn&edition=full","pubTime":"2024-01-30 22:31","pubTimestamp":1706625086,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日22时31分，Immunocore Hldgs Plc股票出现异动，股价大幅跳水8.32%。截至发稿，该股报66.10美元/股，成交量35.7836万股，换手率0.72%，振幅2.16%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.12%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223126875d2e3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223126875d2e3f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393419198","title":"Immunocore Hldgs Plc盘中异动 临近午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393419198","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393419198?lang=zh_cn&edition=full","pubTime":"2023-12-23 00:54","pubTimestamp":1703264095,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日00时54分，Immunocore Hldgs Plc股票出现波动，股价快速上涨5.01%。截至发稿，该股报64.15美元/股，成交量9.0529万股，换手率0.18%，振幅3.63%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为1.66%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122300545587e61553&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122300545587e61553&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393102756","title":"Immunocore Hldgs Plc盘中异动 早盘快速上涨5.49%报61.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393102756","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393102756?lang=zh_cn&edition=full","pubTime":"2023-12-21 22:33","pubTimestamp":1703169184,"startTime":"0","endTime":"0","summary":"北京时间2023年12月21日22时33分，Immunocore Hldgs Plc股票出现波动，股价大幅拉升5.49%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.89%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312212233057a34f128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312212233057a34f128&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391559239","title":"Immunocore Hldgs Plc盘中异动 大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391559239","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391559239?lang=zh_cn&edition=full","pubTime":"2023-12-14 04:37","pubTimestamp":1702499847,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日04时37分，Immunocore Hldgs Plc股票出现异动，股价快速拉升5.04%。截至发稿，该股报64.99美元/股，成交量50.0978万股，换手率1.01%，振幅4.69%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为3.61%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231214043728861c4da8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231214043728861c4da8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2388422471","title":"Immunocore Hldgs Plc盘中异动 下午盘快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388422471","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388422471?lang=zh_cn&edition=full","pubTime":"2023-12-01 02:16","pubTimestamp":1701368182,"startTime":"0","endTime":"0","summary":"北京时间2023年12月01日02时16分，Immunocore Hldgs Plc股票出现异动，股价快速拉升5.09%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.84%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120102162378ff8401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120102162378ff8401&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2384372827","title":"Immunocore Hldgs Plc盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2384372827","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384372827?lang=zh_cn&edition=full","pubTime":"2023-11-16 23:16","pubTimestamp":1700147802,"startTime":"0","endTime":"0","summary":"北京时间2023年11月16日23时16分，Immunocore Hldgs Plc股票出现波动，股价急速跳水5.05%。截至发稿，该股报45.52美元/股，成交量2.5066万股，换手率0.05%，振幅4.34%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.20%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116231642839d335d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116231642839d335d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382243863","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382243863","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382243863?lang=zh_cn&edition=full","pubTime":"2023-11-09 23:41","pubTimestamp":1699544494,"startTime":"0","endTime":"0","summary":"北京时间2023年11月09日23时41分，Immunocore Hldgs Plc股票出现异动，股价大幅跳水5.15%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为1.69%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231109234135847611cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231109234135847611cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2381419241","title":"Immunocore Hldgs Plc盘中异动 股价大涨5.25%报50.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2381419241","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2381419241?lang=zh_cn&edition=full","pubTime":"2023-11-08 02:47","pubTimestamp":1699382825,"startTime":"0","endTime":"0","summary":"北京时间2023年11月08日02时47分，Immunocore Hldgs Plc股票出现异动，股价急速拉升5.25%。截至发稿，该股报50.49美元/股，成交量18.0803万股，换手率0.37%，振幅5.92%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.12%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108024705806a9666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108024705806a9666&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunocore.com","stockEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":-0.0618},{"period":"3month","weight":-0.2149},{"period":"6month","weight":0.2014},{"period":"1year","weight":0.0255},{"period":"ytd","weight":-0.1357}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunocore Holdings plc根据英格兰和威尔士法律于2021年1月7日成立。这是一家后期生物技术公司，致力于开发新型I类TCR双特异性免疫疗法，即ImmTAX–针对X病的免疫动员单克隆TCR。 可治疗多种疾病，包括癌症，传染性疾病和自身免疫性疾病。借助其专有的，灵活的，现成的ImmTAX平台，他们正在多个治疗领域中开发深层次的产品，包括五个在肿瘤学和传染病方面的临床阶段计划，在自身免疫性疾病中进行的高级临床前计划以及多个早期的临床前计划程式。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.069709},{"month":2,"riseRate":0,"avgChangeRate":-0.065247},{"month":3,"riseRate":0.25,"avgChangeRate":0.025389},{"month":4,"riseRate":0.5,"avgChangeRate":0.030449},{"month":5,"riseRate":0.25,"avgChangeRate":-0.041182},{"month":6,"riseRate":0.666667,"avgChangeRate":0.118371},{"month":7,"riseRate":0.666667,"avgChangeRate":0.058322},{"month":8,"riseRate":0.666667,"avgChangeRate":0.017876},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.038729},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037302},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073721},{"month":12,"riseRate":0.333333,"avgChangeRate":0.051882}],"exchange":"NASDAQ","name":"Immunocore Holdings plc","nameEN":"Immunocore Holdings plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunocore Holdings plc,IMCR,Immunocore Holdings plc股票,Immunocore Holdings plc股票老虎,Immunocore Holdings plc股票老虎国际,Immunocore Holdings plc行情,Immunocore Holdings plc股票行情,Immunocore Holdings plc股价,Immunocore Holdings plc股市,Immunocore Holdings plc股票价格,Immunocore Holdings plc股票交易,Immunocore Holdings plc股票购买,Immunocore Holdings plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}